symbol,statement_type,period_end,line_item,value
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Free Cash Flow,14050700000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Repurchase Of Capital Stock,-9302400000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Repayment Of Debt,-11188600000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Issuance Of Debt,6614300000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Issuance Of Capital Stock,
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Capital Expenditure,-25195500000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,End Cash Position,55637900000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,6600000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Beginning Cash Position,33854300000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Effect Of Exchange Rate Changes,91000000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Changes In Cash,21686000000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Financing Cash Flow,1197800000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Net Other Financing Charges,-225000000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Interest Paid Cff,-4203200000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Cash Dividends Paid,-10400000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Common Stock Dividend Paid,
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Net Common Stock Issuance,-9302400000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Common Stock Payments,-9302400000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Common Stock Issuance,
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Net Issuance Payments Of Debt,16037100000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Net Short Term Debt Issuance,20611400000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Short Term Debt Payments,
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Net Long Term Debt Issuance,-4574300000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Long Term Debt Payments,-11188600000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Long Term Debt Issuance,6614300000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Investing Cash Flow,-18758000000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Net Other Investing Changes,2167700000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Interest Received Cfi,3473700000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Dividends Received Cfi,
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Net Investment Purchase And Sale,881600000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Sale Of Investment,1111800000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Purchase Of Investment,-230200000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Net Business Purchase And Sale,-113900000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Sale Of Business,
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Purchase Of Business,-113900000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Net Intangibles Purchase And Sale,-5516900000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Purchase Of Intangibles,-5516900000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Net PPE Purchase And Sale,-19650200000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Sale Of PPE,28400000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Purchase Of PPE,-19678600000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Operating Cash Flow,39246200000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Taxes Refund Paid,-17313500000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Change In Working Capital,-12444800000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Change In Other Current Liabilities,6053300000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Change In Other Current Assets,-3400000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Change In Payable,-3108900000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Change In Inventory,-7354900000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Change In Receivables,-8620800000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Other Non Cash Items,750000000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Provisionand Write Offof Assets,188000000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Depreciation And Amortization,16494200000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Amortization Cash Flow,
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Depreciation,16494200000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Investment Securities,-198200000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,587100000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Sale Of PPE,89400000.0
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Sale Of Business,
AUROPHARMA.NS,cashflow,2025-03-31 00:00:00,Net Income From Continuing Operations,50662900000.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Free Cash Flow,-11269800000.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Repurchase Of Capital Stock,0.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Repayment Of Debt,-171700000.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Issuance Of Debt,15632400000.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Issuance Of Capital Stock,
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Capital Expenditure,-35615000000.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,End Cash Position,33854300000.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Beginning Cash Position,43922700000.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Effect Of Exchange Rate Changes,141700000.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Changes In Cash,-10210100000.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Financing Cash Flow,8004200000.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Net Other Financing Charges,
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Interest Paid Cff,-2506500000.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Cash Dividends Paid,-2636400000.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Common Stock Dividend Paid,
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Net Common Stock Issuance,0.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Common Stock Payments,0.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Common Stock Issuance,
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Net Issuance Payments Of Debt,14613100000.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Net Short Term Debt Issuance,-847600000.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Short Term Debt Payments,
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Net Long Term Debt Issuance,15460700000.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Long Term Debt Payments,-171700000.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Long Term Debt Issuance,15632400000.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Investing Cash Flow,-42559500000.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Net Other Investing Changes,-11890200000.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Interest Received Cfi,2808400000.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Dividends Received Cfi,
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Net Investment Purchase And Sale,1534500000.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Sale Of Investment,1770400000.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Purchase Of Investment,-235900000.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Net Business Purchase And Sale,0.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Sale Of Business,
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Purchase Of Business,0.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Net Intangibles Purchase And Sale,-7811700000.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Purchase Of Intangibles,-7811700000.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Net PPE Purchase And Sale,-27200500000.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Sale Of PPE,602800000.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Purchase Of PPE,-27803300000.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Operating Cash Flow,24345200000.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Taxes Refund Paid,-17666400000.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Change In Working Capital,-16750700000.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Change In Other Current Liabilities,539800000.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Change In Other Current Assets,-8425700000.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Change In Payable,5828400000.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Change In Inventory,-13036800000.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Change In Receivables,-2641900000.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Other Non Cash Items,-277200000.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Provisionand Write Offof Assets,232800000.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Depreciation And Amortization,15216600000.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Amortization Cash Flow,5737700000.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Depreciation,15216600000.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Investment Securities,-28000000.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,-511400000.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Sale Of PPE,-234900000.0
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Sale Of Business,
AUROPHARMA.NS,cashflow,2024-03-31 00:00:00,Net Income From Continuing Operations,43799900000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Free Cash Flow,-3336500000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Repurchase Of Capital Stock,
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Repayment Of Debt,-56500000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Issuance Of Debt,3935800000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Issuance Of Capital Stock,
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Capital Expenditure,-27204000000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,End Cash Position,43922700000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,64100000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Beginning Cash Position,41625100000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Effect Of Exchange Rate Changes,-600000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Changes In Cash,2234100000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Financing Cash Flow,18144100000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Net Other Financing Charges,
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Interest Paid Cff,-1112000000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Cash Dividends Paid,-4395300000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Common Stock Dividend Paid,-4395300000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Net Common Stock Issuance,
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Common Stock Payments,
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Common Stock Issuance,
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Net Issuance Payments Of Debt,24576100000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Net Short Term Debt Issuance,20696800000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Short Term Debt Payments,
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Net Long Term Debt Issuance,3879300000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Long Term Debt Payments,-56500000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Long Term Debt Issuance,3935800000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Investing Cash Flow,-39777500000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Net Other Investing Changes,-16608400000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Interest Received Cfi,1466200000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Dividends Received Cfi,
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Net Investment Purchase And Sale,3373700000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Sale Of Investment,23514700000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Purchase Of Investment,-20141000000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Net Business Purchase And Sale,-915900000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Sale Of Business,1053800000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Purchase Of Business,-1969700000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Net Intangibles Purchase And Sale,-3166000000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Purchase Of Intangibles,-3166000000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Net PPE Purchase And Sale,-23927100000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Sale Of PPE,110900000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Purchase Of PPE,-24038000000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Operating Cash Flow,23867500000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Taxes Refund Paid,-7172400000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Change In Working Capital,-10949800000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Change In Other Current Liabilities,1087500000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Change In Other Current Assets,-5753600000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Change In Payable,7076500000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Change In Inventory,-9267000000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Change In Receivables,-4310700000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Other Non Cash Items,-299600000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Provisionand Write Offof Assets,524500000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Depreciation And Amortization,12445800000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Amortization Cash Flow,4112900000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Depreciation,8332900000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Investment Securities,-191400000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,3104600000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Sale Of PPE,-132300000.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Sale Of Business,0.0
AUROPHARMA.NS,cashflow,2023-03-31 00:00:00,Net Income From Continuing Operations,26125000000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Free Cash Flow,23118400000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Repurchase Of Capital Stock,
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Repayment Of Debt,0.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Issuance Of Debt,827300000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Issuance Of Capital Stock,
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Capital Expenditure,-27046400000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,End Cash Position,41625100000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,-32500000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Beginning Cash Position,53299100000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Effect Of Exchange Rate Changes,2000000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Changes In Cash,-11643500000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Financing Cash Flow,-29692700000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Net Other Financing Charges,
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Interest Paid Cff,-185000000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Cash Dividends Paid,-2637000000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Common Stock Dividend Paid,-2637000000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Net Common Stock Issuance,
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Common Stock Payments,
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Common Stock Issuance,
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Net Issuance Payments Of Debt,-25539300000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Net Short Term Debt Issuance,-26366600000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Short Term Debt Payments,-26366600000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Net Long Term Debt Issuance,827300000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Long Term Debt Payments,0.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Long Term Debt Issuance,827300000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Investing Cash Flow,-32115600000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Net Other Investing Changes,749300000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Interest Received Cfi,252600000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Dividends Received Cfi,
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Net Investment Purchase And Sale,-3633000000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Sale Of Investment,4616500000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Purchase Of Investment,-8249500000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Net Business Purchase And Sale,-6247500000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Sale Of Business,292900000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Purchase Of Business,-6540400000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Net Intangibles Purchase And Sale,-6517300000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Purchase Of Intangibles,-6517300000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Net PPE Purchase And Sale,-16719700000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Sale Of PPE,3809400000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Purchase Of PPE,-20529100000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Operating Cash Flow,50164800000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Taxes Refund Paid,-12581900000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Change In Working Capital,15578000000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Change In Other Current Liabilities,3328100000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Change In Other Current Assets,105900000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Change In Payable,1106500000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Change In Inventory,14975200000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Change In Receivables,-4082900000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Other Non Cash Items,122800000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Provisionand Write Offof Assets,-61100000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Depreciation And Amortization,11265200000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Amortization Cash Flow,3286600000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Depreciation,7978600000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Investment Securities,-611000000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,1049700000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Sale Of PPE,1350200000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Sale Of Business,26500000.0
AUROPHARMA.NS,cashflow,2022-03-31 00:00:00,Net Income From Continuing Operations,33727400000.0
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Free Cash Flow,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Repurchase Of Capital Stock,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Repayment Of Debt,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Issuance Of Debt,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Issuance Of Capital Stock,0.0
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Capital Expenditure,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,End Cash Position,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,224100000.0
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Beginning Cash Position,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Effect Of Exchange Rate Changes,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Changes In Cash,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Financing Cash Flow,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Net Other Financing Charges,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Interest Paid Cff,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Cash Dividends Paid,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Common Stock Dividend Paid,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Net Common Stock Issuance,0.0
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Common Stock Payments,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Common Stock Issuance,0.0
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Net Issuance Payments Of Debt,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Net Short Term Debt Issuance,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Short Term Debt Payments,-6678200000.0
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Net Long Term Debt Issuance,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Long Term Debt Payments,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Long Term Debt Issuance,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Investing Cash Flow,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Net Other Investing Changes,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Interest Received Cfi,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Dividends Received Cfi,0.0
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Net Investment Purchase And Sale,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Sale Of Investment,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Purchase Of Investment,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Net Business Purchase And Sale,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Sale Of Business,31739100000.0
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Purchase Of Business,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Net Intangibles Purchase And Sale,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Purchase Of Intangibles,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Net PPE Purchase And Sale,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Sale Of PPE,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Purchase Of PPE,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Operating Cash Flow,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Taxes Refund Paid,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Change In Working Capital,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Change In Other Current Liabilities,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Change In Other Current Assets,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Change In Payable,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Change In Inventory,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Change In Receivables,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Other Non Cash Items,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Provisionand Write Offof Assets,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Depreciation And Amortization,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Amortization Cash Flow,2537800000.0
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Depreciation,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Investment Securities,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Sale Of PPE,
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Sale Of Business,-32495000000.0
AUROPHARMA.NS,cashflow,2021-03-31 00:00:00,Net Income From Continuing Operations,
